Topic Archives: Advaxis (ADXS)

March 16, 2017 / Travis Johnson, Stock Gumshoe

What’s the “Silver Bullet” Cancer Vaccine Company Pitched by Disruptors and Dominators?

The Disruptors and Dominators newsletter, one of the “entry level” letters from Weiss, is out pitching a “silver bullet” company — a firm that has developed a universal cancer vaccine. And, of course, they’ll tell you all about it — for your $49 subscription fee. Here at Stock Gumshoe, we’d like you to think things […]

October 29, 2014 / Travis Johnson, Stock Gumshoe

“It’s going to be the ‘Apple’ of cancer therapy in the next 20 years.”

Immunotherapy for cancer has been in the news quite a bit in recent years, with several drugs making an impact on the worst cancers and giving some real hope for future advancement — not a small thing for a basic medical strategy that’s been tested and tweaked for 125 years now by folks following in […]

Comments

carl adrianopoli on Blanco’s ” $2 Trillion ‘Bio-Switch'” Stock — he says it’s “Hailed as Miracle Drug for 3 Killer Diseases” / Mar 12, 6:35pm

Resverlogix has no ongoing clinical trial on the ClinicalTrials.gov site. Not sure what they are addressing. There are s...

Kris Prasad on written by reader

The Gain from Pain Mainly Explained: Fire Walk with Me / Oct 27, 11:22am

For those considering Advaxis (ADXS) which Dr.KSS and Jean-Pierre Ruiz discussed earlier I found some non-scientific inf...

DrKSSMDPhD on written by reader

The Gain from Pain Mainly Explained: Fire Walk with Me / Oct 23, 5:14pm

I appreciate JP Ruiz mining so much helpful information on Advaxis $ADXS. This company is a play on the immune stimul...

sandiegojp on written by reader

The Gain from Pain Mainly Explained: Fire Walk with Me / Oct 23, 3:04pm

Advaxis (ADXS) is listed on the NASDAQ. It's 52-week range is $2.46 - $5.99 with average volume of 250,914 shares. Marke...